Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults

Determination of Remifentanil's ED50 for Rapid Sequence Intubation Avoiding Bradycardia and Hypotension in Adults

This study will find the median effective dose of remifentanil for rapid sequence intubation which avoids bradycardia and hypotension

Remifentanil is becoming popular for rapid sequence intubation because it has a fast onset and ultra-short half-life.

Remifentanil a potent opioid associated to bradycardia and hypotension at high doses.

Inclusion Criteria:

• Indication of anesthesia induction

Exclusion Criteria:

• Protocol violation
• Monitoring problems